About SHSSX
BlackRock Health Sciences Opportunities Fund Institutional Shares is a mutual fund specializing in the health sciences sector. Its primary objective is to provide investment returns by allocating at least 80% of its total assets to equity securities of companies engaged in health sciences and related industries, encompassing subsectors such as pharmaceuticals, biotechnology, healthcare equipment and supplies, and healthcare services. The fund maintains a concentrated portfolio, often investing more than a quarter of its assets in this sector, and includes holdings from both U.S. and international companies to enhance diversification.
With a notable emphasis on large, innovative healthcare firms, the fund frequently lists prominent industry leaders such as Eli Lilly, UnitedHealth Group, AbbVie, and Boston Scientific among its top positions. Managed by BlackRock’s experienced team, the fund aims for diversified returns while maintaining a risk profile below the broad equity market average, as reflected by its lower long-term beta. Its institutional share class targets large-scale investors, requiring a substantial minimum investment. The fund’s role in the financial market is to offer targeted exposure to the dynamic and evolving healthcare sector, helping institutional investors participate in the growth and resilience characteristic of health sciences industries.
Fund Family BlackRock
Category Health
Performance Rating Above Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol SHSSX
Share Class Institutional
Index Russell 3000 Healthcare TR
SHSSX had a total return of 31.94% in the past year, including dividends. Since the fund's
inception, the average annual return has been 12.51%.
